Japan’s Takeda suspends new clinical trials in Russia
By Trend
Takeda Pharmaceutical has suspended new clinical trials of drugs in Russia due to the situation around Ukraine, Trend reports citing TASS.
The company will also halt new investments in Russia. Supplies of drugs and clinical trials will continue. Sanctions against Russia do not apply to the pharmaceutical business but introduced restrictions made logistics and transactions more challenging.
Astellas Pharma, another Japanese pharmaceutical company, also suspended enrollment new patients in Russia and Ukraine for clinical trials of their pharmaceuticals.
--
Follow us on Twitter @AzerNewsAz
Here we are to serve you with news right now. It does not cost much, but worth your attention.
Choose to support open, independent, quality journalism and subscribe on a monthly basis.
By subscribing to our online newspaper, you can have full digital access to all news, analysis, and much more.
You can also follow AzerNEWS on Twitter @AzerNewsAz or Facebook @AzerNewsNewspaper
Thank you!